HK1063292A1 - Active ingredient combination (E.G- galanthamine. e or desoxypeganine with acamprosate or memantine)for treating a dependence on addictive substances or narcotics. - Google Patents

Active ingredient combination (E.G- galanthamine. e or desoxypeganine with acamprosate or memantine)for treating a dependence on addictive substances or narcotics.

Info

Publication number: HK1063292A1
Authority: HK; Hong Kong
Prior art keywords: desoxypeganine; acamprosate; galanthamine; narcotics; memantine
Prior art date: 2001-06-18

Application number

HK04106071A

Other languages

English (en)

Inventor

Joachim Moormann

Hermann Mucke

Klaus Opitz

Original Assignee

Hf Arzneimittelforsch Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-18

Filing date

2004-08-12

Publication date

2004-12-24

2004-08-12 Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh

2004-12-24 Publication of HK1063292A1 publication Critical patent/HK1063292A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Detergent Compositions (AREA)

HK04106071A 2001-06-18 2004-08-12 Active ingredient combination (E.G- galanthamine. e or desoxypeganine with acamprosate or memantine)for treating a dependence on addictive substances or narcotics. HK1063292A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10129265A DE10129265A1 (de)	2001-06-18	2001-06-18	Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
PCT/EP2002/006630 WO2002102388A2 (de)	2001-06-18	2002-06-15	Wirkstoffkombination von z.b. galanthamin oder desoxypeganin mit z.b. acamprosat oder memantin gegen sucht wie z.b. alkoholismus

Publications (1)

Publication Number	Publication Date
HK1063292A1 true HK1063292A1 (en)	2004-12-24

Family

ID=7688529

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK04106071A HK1063292A1 (en)	2001-06-18	2004-08-12	Active ingredient combination (E.G- galanthamine. e or desoxypeganine with acamprosate or memantine)for treating a dependence on addictive substances or narcotics.

Country Status (28)

Country	Link
US (1)	US20040192683A1 (xx)
EP (1)	EP1397138B1 (xx)
JP (1)	JP2005500298A (xx)
KR (1)	KR20040010744A (xx)
CN (1)	CN1527711A (xx)
AR (1)	AR034493A1 (xx)
AT (1)	ATE286397T1 (xx)
AU (1)	AU2002323873B2 (xx)
BR (1)	BR0211008A (xx)
CA (1)	CA2450787C (xx)
CZ (1)	CZ299951B6 (xx)
DE (2)	DE10129265A1 (xx)
EA (1)	EA006647B1 (xx)
ES (1)	ES2236551T3 (xx)
HK (1)	HK1063292A1 (xx)
HU (1)	HUP0400865A3 (xx)
IL (2)	IL159345A0 (xx)
MX (1)	MXPA03011825A (xx)
MY (1)	MY129726A (xx)
NO (1)	NO20035458D0 (xx)
NZ (1)	NZ529944A (xx)
PL (1)	PL367207A1 (xx)
PT (1)	PT1397138E (xx)
SK (1)	SK287180B6 (xx)
TW (1)	TWI325320B (xx)
UA (1)	UA76753C2 (xx)
WO (1)	WO2002102388A2 (xx)
ZA (1)	ZA200309232B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10134038A1 (de) *	2001-07-12	2003-02-06	Hf Arzneimittelforsch Gmbh	Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10318714B4 (de) *	2003-04-25	2006-03-23	Hf Arzneimittelforschung Gmbh	Wirkstoff-Kombinationen und Therapien zur Bekämpfung des Alkoholmissbrauches
DE10354894A1 (de) *	2003-11-24	2005-07-07	Hf Arzneimittelforschung Gmbh	Orale Formulierungen des Desoxypeganins und deren Anwendungen
DE102004048927A1 (de) *	2004-10-06	2006-04-20	Lts Lohmann Therapie-Systeme Ag	Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren
US7619007B2 (en)	2004-11-23	2009-11-17	Adamas Pharmaceuticals, Inc.	Method and composition for administering an NMDA receptor antagonist to a subject
DE602006016934D1 (de)	2005-04-06	2010-10-28	Adamas Pharmaceuticals Inc	Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen
US8632800B2 (en) *	2005-05-13	2014-01-21	Alza Corporation	Multilayer drug delivery system with barrier against reservoir material flow
EP2202259B1 (en)	2005-09-01	2012-02-29	Mitsubishi Chemical Corporation	Method of multistage solid-phase polycondensation of polyethylene terephthalate
WO2007035941A2 (en) *	2005-09-23	2007-03-29	Alza Corporation	Transdermal galantamine delivery system
WO2010093859A1 (en)	2009-02-12	2010-08-19	Indiana University Research & Technology Corporation	Material and methods for treating developmental disorders including comorbid and idiopathic autism
CA2782556C (en)	2009-12-02	2018-03-27	Adamas Pharmaceuticals, Inc.	Amantadine compositions and methods of use
EP2621487B1 (en)	2010-09-28	2017-05-03	Depomed, Inc.	Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
FI3884947T3 (fi) *	2010-12-03	2024-01-30	Nalpropion Pharmaceuticals Llc	Lääkkeen hyötyosuuden lisääminen naltreksonihoidossa
WO2013160728A1 (en)	2012-04-26	2013-10-31	Alma Mater Studiorum - Universita' Di Bologna	Dual targeting compounds for the treatment of alzheimer's disease
US10154971B2 (en)	2013-06-17	2018-12-18	Adamas Pharma, Llc	Methods of administering amantadine
CN108210486B (zh) *	2016-12-14	2020-05-19	陆汝斌	组合物用于制备治疗酒瘾或酒精滥用的药物的用途
WO2019040748A1 (en)	2017-08-24	2019-02-28	Adamas Pharma, Llc	AMANTADINE COMPOSITIONS, THEIR PREPARATION, AND METHODS OF USE
BG67408B1 (bg) *	2019-04-12	2022-01-17	Софарма Ад	Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3797494A (en) *	1969-04-01	1974-03-19	Alza Corp	Bandage for the administration of drug by controlled metering through microporous materials
US3742951A (en) *	1971-08-09	1973-07-03	Alza Corp	Bandage for controlled release of vasodilators
US3996934A (en) *	1971-08-09	1976-12-14	Alza Corporation	Medical bandage
US4031894A (en) *	1975-12-08	1977-06-28	Alza Corporation	Bandage for transdermally administering scopolamine to prevent nausea
DE3315272C2 (de) *	1983-04-27	1986-03-27	Lohmann Gmbh & Co Kg, 5450 Neuwied	Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
DE3843239C1 (xx) *	1988-12-22	1990-02-22	Lohmann Therapie Syst Lts
EP0424179A3 (en) *	1989-10-20	1991-12-27	John William Olney	Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration
DE4010079A1 (de) *	1990-03-29	1991-10-02	Lohmann Therapie Syst Lts	Pharmazeutische formulierung zur behandlung des alkoholismus
US5519017A (en) *	1990-03-29	1996-05-21	Lts Lohmann Therapie-Systeme Gmbh + Co. Kg	Pharmaceutic formulation for the treatment of alcoholism
US5668117A (en) *	1991-02-22	1997-09-16	Shapiro; Howard K.	Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
DK0787115T3 (da) *	1994-10-21	2000-05-08	Sanochemia Pharmazeutika Ag	Fremgangsmåde til fremstilling af 4a,5,9,10,11,12-hexahydro-6H-benzofuro[3a,3,2-ef][2]benzazepinderivater
DE19509663A1 (de) *	1995-03-17	1996-09-19	Lohmann Therapie Syst Lts	Verfahren zur Isolierung von Galanthamin
GB9514821D0 (en) *	1995-07-19	1995-09-20	Sod Conseils Rech Applic	Galanthamine derivatives
AT403803B (de) *	1996-04-19	1998-05-25	Sanochemia Ltd	Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
EP0945133A1 (en) *	1998-03-26	1999-09-29	Lipha	Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator
NZ507585A (en) *	1998-04-17	2003-11-28	Kenneth Curry	Cubane analogs with activity at the metabotropic glutamate receptors
DE19906974C2 (de) *	1999-02-19	2003-10-09	Lohmann Therapie Syst Lts	Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906979B4 (de) *	1999-02-19	2004-07-08	Lts Lohmann Therapie-Systeme Ag	Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906978B4 (de) *	1999-02-19	2004-07-08	Lts Lohmann Therapie-Systeme Ag	Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit

2001
- 2001-06-18 DE DE10129265A patent/DE10129265A1/de not_active Withdrawn
2002
- 2002-06-14 AR ARP020102244A patent/AR034493A1/es unknown
- 2002-06-15 MX MXPA03011825A patent/MXPA03011825A/es active IP Right Grant
- 2002-06-15 EA EA200400041A patent/EA006647B1/ru not_active IP Right Cessation
- 2002-06-15 KR KR10-2003-7016570A patent/KR20040010744A/ko active Search and Examination
- 2002-06-15 PT PT02754688T patent/PT1397138E/pt unknown
- 2002-06-15 CN CNA028110196A patent/CN1527711A/zh active Pending
- 2002-06-15 SK SK1565-2003A patent/SK287180B6/sk not_active IP Right Cessation
- 2002-06-15 US US10/480,287 patent/US20040192683A1/en not_active Abandoned
- 2002-06-15 EP EP02754688A patent/EP1397138B1/de not_active Expired - Lifetime
- 2002-06-15 JP JP2003504974A patent/JP2005500298A/ja active Pending
- 2002-06-15 AT AT02754688T patent/ATE286397T1/de not_active IP Right Cessation
- 2002-06-15 IL IL15934502A patent/IL159345A0/xx active IP Right Grant
- 2002-06-15 AU AU2002323873A patent/AU2002323873B2/en not_active Ceased
- 2002-06-15 UA UA20031211802A patent/UA76753C2/uk unknown
- 2002-06-15 WO PCT/EP2002/006630 patent/WO2002102388A2/de active IP Right Grant
- 2002-06-15 NZ NZ529944A patent/NZ529944A/en unknown
- 2002-06-15 ES ES02754688T patent/ES2236551T3/es not_active Expired - Lifetime
- 2002-06-15 CA CA002450787A patent/CA2450787C/en not_active Expired - Fee Related
- 2002-06-15 CZ CZ20033390A patent/CZ299951B6/cs not_active IP Right Cessation
- 2002-06-15 DE DE50201958T patent/DE50201958D1/de not_active Expired - Lifetime
- 2002-06-15 HU HU0400865A patent/HUP0400865A3/hu unknown
- 2002-06-15 BR BR0211008-3A patent/BR0211008A/pt not_active Application Discontinuation
- 2002-06-15 PL PL02367207A patent/PL367207A1/xx unknown
- 2002-06-17 TW TW091113176A patent/TWI325320B/zh not_active IP Right Cessation
- 2002-06-17 MY MYPI20022245A patent/MY129726A/en unknown
2003
- 2003-11-27 ZA ZA200309232A patent/ZA200309232B/xx unknown
- 2003-12-08 NO NO20035458A patent/NO20035458D0/no not_active Application Discontinuation
- 2003-12-11 IL IL159345A patent/IL159345A/en not_active IP Right Cessation
2004
- 2004-08-12 HK HK04106071A patent/HK1063292A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE50201958D1 (de)	2005-02-10
HUP0400865A3 (en)	2011-03-28
EP1397138A2 (de)	2004-03-17
WO2002102388A3 (de)	2003-09-18
AU2002323873B2 (en)	2006-11-16
NO20035458D0 (no)	2003-12-08
AR034493A1 (es)	2004-02-25
CZ299951B6 (cs)	2009-01-07
MXPA03011825A (es)	2005-03-07
PL367207A1 (en)	2005-02-21
EA200400041A1 (ru)	2004-04-29
ZA200309232B (en)	2004-07-21
CN1527711A (zh)	2004-09-08
SK15652003A3 (sk)	2004-04-06
WO2002102388A2 (de)	2002-12-27
PT1397138E (pt)	2005-04-29
EA006647B1 (ru)	2006-02-24
CZ20033390A3 (en)	2004-03-17
NZ529944A (en)	2007-02-23
UA76753C2 (uk)	2006-09-15
TWI325320B (en)	2010-06-01
CA2450787A1 (en)	2002-12-27
IL159345A (en)	2009-02-11
HUP0400865A2 (hu)	2004-07-28
IL159345A0 (en)	2004-06-01
JP2005500298A (ja)	2005-01-06
BR0211008A (pt)	2004-10-26
CA2450787C (en)	2009-06-02
ES2236551T3 (es)	2005-07-16
US20040192683A1 (en)	2004-09-30
ATE286397T1 (de)	2005-01-15
EP1397138B1 (de)	2005-01-05
SK287180B6 (sk)	2010-02-08
MY129726A (en)	2007-04-30
DE10129265A1 (de)	2003-01-02
KR20040010744A (ko)	2004-01-31

Publication	Publication Date	Title
HK1063292A1 (en)	2004-12-24	Active ingredient combination (E.G- galanthamine. e or desoxypeganine with acamprosate or memantine)for treating a dependence on addictive substances or narcotics.
MXPA03005988A (es)	2003-09-10	Dispositivo para suministro de volumen liquido.
MXPA03002874A (es)	2004-02-12	Sistema de suministro de pesticida.
EG23400A (en)	2005-05-31	Database.
MXPA03006231A (es)	2003-09-22	Dispensador con funciones multiples.
MXPA03006775A (es)	2003-10-24	Formulacion farmaceutica.
ZA200204582B (en)	2003-07-30	Immunoassay for neonicotinyl insecticides.
MXPA03007641A (es)	2003-12-04	Formulacion farmaceutica.
MXPA03009804A (es)	2004-01-29	DISPENSADOR DE FORMAS DE DOSIFICACIoN SoLIDAS.
MXPA03005568A (es)	2003-10-06	Composicion herbicida.
AP2004002955A0 (en)	2004-03-31	Weed control doses.
ZA200200031B (en)	2002-07-03	Safety catch for pistols.
MXPA03001263A (es)	2003-06-24	Formulacion fungicida.
ZA200102716B (en)	2001-10-05	Solid pesticidal formulation.
ZA200307052B (en)	2005-04-26	A safety and harvesting device.
MXPA03007384A (es)	2003-12-04	Emulsificantes, especialmente a base de poliisobutilenaminas.
Kielsmeier	2000	Service-learning
ZA200300237B (en)	2003-08-01	A locking device.
AU2002348701A1 (en)	2003-06-23	A locking device
Barman	2001	The Nyaya concept of Prama: a critical study
ZA200110224B (en)	2002-07-09	"Client/server systems".
ZA200204334B (en)	2003-01-27	Locking device.
ZA200200264B (en)	2003-04-30	Remedies for drug-resistant hypercalcemia.
ZA200205431B (en)	2003-03-18	A medicament.
Reinhart	2000	Ha-rabā yōter hegyōnī laševet šalōm

Legal Events

Date	Code	Title	Description
2012-01-27	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20110615